Clinical Trial Biorepository & Archiving Solutions Market
Market Insights on Clinical Trial Biorepository & Archiving Solutions covering sales outlook, demand forecast & up-to-date key trends
Clinical Trial Biorepository & Archiving Solutions Market by Product Type, Phase, Application & Region - Forecast 2022 - 2032
Clinical Trial Biorepository & Archiving Solutions Market Snapshot (2022-2032)
[250 Pages Report] Newly-released Clinical Trial Biorepository & Archiving Solutions Market analysis report by Future Market Insights shows that global sales of Clinical Trial Biorepository & Archiving Solutions Market in 2021 was held at US$ 3.5 Bn. With 12.1%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth. Clinical Products are expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 11.9% from 2022 – to 2032.
|
Attributes |
Details |
|
Clinical Trial Biorepository & Archiving Solutions Market CAGR (2022-2032) |
12.1% |
|
Clinical Trial Biorepository & Archiving Solutions Market Size (2022) |
US$ 3.9 Bn |
|
Clinical Trial Biorepository & Archiving Solutions Market Size (2032) |
US$ 12.2 Bn |
Let us know your requirement to get
100% FREE customization
Revenue of Clinical Trial Biorepository & Archiving Solutions Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032
According to the Clinical Trial Biorepository & Archiving Solutions Market research conducted by Future Market Insights, market research and competitive intelligence provider, the market value of the Clinical Trial Biorepository & Archiving Solutions Market increased at a CAGR of around 12.1% from 2017 to 2021.
The market growth is mainly due to the enhancement in the fields of depersonalized and genomic medicine. Also, the push to streamline data collecting and reporting by adopting software such as Laboratory Information Management for laboratory sample tests have been augmenting the market growth. The UB Biorepository is a key new institution at the Clinical and Experimental Research Center that will be a vital resource in advancing biomedical innovations in academics and businesses. The center has the potential to gather, analyze, preserve, and disseminate millions of tissue samples, allowing UB and its academic and commercial partners to utilize the findings that will eventually help patients.
The clinical products category held the largest market share with a CAGR of 11.9% in 2021 and earned more revenue than other product types. Cell & Co., a company that provides biorepository and transport services for the life science sector was incorporated in 2012 and reported sales of over 2.6 million Euros in 2021.
Big data have made inroads in biorepositories, which are mainly focused on the use of modern information technologies for storage, to be interpreted with artificial intelligence, machine learning, and also deep learning tools and algorithms. Tech companies are seeking to disrupt the traditional method of conducting clinical trials.
What Factors are Propelling Clinical Trial Biorepository & Archiving Solutions Demand?
The attempt to modernize clinical trials involves extracting voluminous information through healthcare data, integrating telehealth in decentralized studies done partially or wholly digitally to attract a broader range of respondents, and using devices to collect additional data.
The market is growing at a fast pace due to the increased availability of low-cost devices and also the desire to build data compilation and easy reporting by using software similar to a laboratory information management system, which is mainly made to be used by the management of samples in laboratories.
Machine learning techniques for evaluating a patient's condition improve information finding by allowing users to find related instances, develop normalcy statistics, and detect outliers. Such methods are used for diagnostics or risk analysis having the potential to improve healthcare. The International Society for Biological and Environmental Repositories has made its position in the world as a leader for bio storage technology standardization. To standardize biorepository standards, the College of American Pathologists created the first biorepository accreditation program that complies with severe requirements.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich Phase of the Clinical Trial Biorepository & Archiving Solutions Market is expected to Offer the Largest Opportunity?
Phase III clinical trials are expected to account for over 50% of the market in 2020. Clinical trials are often carried out in stages that build on one other. Phase III clinical studies assess the novel treatment's safety and efficacy to the existing level of care. While doctors are unsure whether therapy is superior, research participants are typically assigned to either the conventional or novel treatment at random. When feasible, neither the therapist nor sufferer is aware of which treatment is being administered.
In addition, because of the large number of participants and the duration of the phase, long-term and unusual side effects are more likely to come across. The goal of phase 3 studies is to show and validate that the medicine is a safe, useful, and appropriate cure for the targeted application based on the preliminary data acquired in prior trials. Burjeel Medical City in Abu Dhabi, for instance, is ready to start two Phase 3 clinical studies of Mitapivat, a novel, first-in-class enzyme-activating medication (AG-348).
Which Region is projected to Offer the Largest Opportunity for Clinical Trial Biorepository & Archiving Solutions Market?
In 2021, the global Clinical Trial Biorepository & Archiving Solutions market was dominated by North America. One of the key factors driving the regional market is the increase in the frequency of clinical trials. Besides, the existence of a large number of companies in the industry further paves way for the fast-paced growth of the clinical trial biorepository & archiving solutions market.
Pharma Biotech, a North American Clinical Testing firm, recently announced that it has entered a deal with CCrest Laboratories Inc., allowing it to distribute its GMP MDMA to users in Canada and across the globe through preclinical study in two patent-protected Chemical Entities (NCEs) relying on MDXX category molecules also had initiated at PharmAla's R&D unit, with proof-of-concept studies currently underway at the University of Arkansas School for Medical Sciences in the United States and after Vivo Solutions in Canada.
Asia Pacific is expected to gain significant market share at the fastest rate among regions, throughout the forecast period. For instance, SCG Cell Treatment Pte Ltd ("SCG"), a prominent biotechnology firm located in Singapore, announced that Singapore Health Sciences Authority (HSA) has approved SCG101, an autologous T-cell receptor (TCR) T-cell treatment, for medical studies.
SCG101 has been known to prevent hepatocellular carcinoma (HCC), the most prevalent type of liver cancer, caused by the hepatitis B virus (HBV). Specifically, clinical research is expected to grow at an increasing rate. As per a Pharma IQ poll, 60% of respondents noticed China and India as promising areas for clinical research in the next five years.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-wise Analysis
Which Country Holds the Highest Market Revenue for Clinical Trial Biorepository & Archiving Solutions?
The United States is expected to possess the largest market value of around US$ 5 Bn by the end of 2032. Pharmaceutical firms in the United States invest more heavily in research and development than most other businesses. Clinical research funding by the National Institutes of Health was roughly US$ 17.6 bn US dollars in 2020, as compared to US$ 15 Bn in 2019. As per the National Clinical Studies Registry (NCT), there were roughly 11,865 open clinical studies in various stages for cancer indications in the United States in 2020.
The expanding use of clinical trials Biorepository & Archiving Solutions, as well as the existence of large companies and the availability of modern technology, are boosting the market in the United States. UC San Diego bioengineers and cardiologists have invented a device for mapping irregular heart arrhythmias called Bioengineers V.A. TravalasRE INR for Cardiologists, Inc., the company co-founded by UCSD faculty, created the technology. Its validation study showed the device had an average accuracy of 97.3%.
Category-wise Insights
Why Clinical Products is projected to Witness the Fastest Growth among Clinical Trial Biorepository & Archiving Solutions Types?
Among product types, revenue through Clinical Products is forecasted to grow at the highest CAGR of over 11.9% during 2022-2032. This is because the frequency of clinical trial enrolment has increased over the years. ClinicalTrials.gov stated that 386,583 studies have been recorded in 219 nations as of August 2021, compared to 362,524 tests in 2020 and almost 325,787 tests in 2019. Adding to the development, of Stimwave Technology the level-1 FREEDOM clinical study series which provides multi, progressive, randomized trials that track chronic pain sufferers' reactions to peripheral nerve stimulation (PNS) throughout the years. FREEDOM-1 is Stimwave's first clinical trial evaluating the Stimwave Freedom PNS device for treating patients with persistent knee pain.
Which Application of Clinical Trial Biorepository & Archiving Solutions is expected to Score Highest Growth in the Coming Years?
Revenue through Biorepository Services in Clinical Trial Biorepository & Archiving Solutions is expected to command the largest revenue as well as a CAGR of nearly 12.1%, during the forecast period. Biorepositories are an essential aspect of successful healthcare as they provide tools for translational biomedical research, in vitro technology guidance through the FDA procedures, diagnostic technique testing and evaluation, and customized medication. The Health Insurance Portability and Accountability Act, the Right to Withdraw, the European Union General Data Protection Regulation, and other regulations governing the sample custody and ownership, human tissues, and access to biospecimens are likely to improve data security and patient privacy.
What is the impact of Covid-19 on the Clinical Trial Biorepository & Archiving Solutions Market?
The COVID-19 outbreak posed several hurdles to medical systems, particularly medical research programs in cancer. Oncology clinical trial testing, registration, and study practices suffered significant unfavorable consequences that forced institutional and regulatory agencies to devise novel methods to sustain strong and equal engagement in such studies. In addition, the US Food and Drug Administration's Oncology Centers of Excellence was already engaged in a large number of initiatives to tackle issues for cancer survivors during the COVID-19 epidemic, including publishing guideline manuals and helping to update clinical trials.
The clinical cycle for the patient has been simplified owing to the digital pathology developments at Memorial Sloan Kettering Cancer Center. Pathologists may examine specimens from anywhere since there are pathological labs nearby that can analyze and scan glass slides that decrease risk and keeps the pathology industry in place.
Competitive Analysis
Companies are adopting a variety of tactical methods to improve their services and obtain a competitive edge over their competitors, such as geographical growth, new business contracts, mergers and acquisitions, and partnerships.
Some of the recent developments of key Clinical Trial Biorepository & Archiving Solutions providers are as follows:
- In January 2020, Brooks Life Sciences expanded the capacity of its Indianapolis biorepository to boost its biobanking and sample management capabilities. Clients in academia and pharma who wanted to speed up clinical studies and find answers benefited from this growth.
- In March 2020, ATCC has joined hands with the Global Scientific Community. Taking Covid19 into consideration, the collaboration sought to expand its assistance to the US and foreign R&D communities.
Similarly, recent developments related to companies’ Clinical Trial Biorepository & Archiving Solutions services have been tracked by the team at Future Market Insights, which are available in the full report.
Clinical Trial Biorepository & Archiving Solutions Market Report Scope
|
Attribute |
Details |
|
Forecast Period |
2022-2032 |
|
Historical Data Available for |
2017-2021 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, Asia Pacific, Middle East & Africa |
|
Key Countries Covered |
United States, Canada, Brazil, Mexico, Germany, U.K., France, Spain, Italy, Russia, China, Japan, South Korea, India, Australia, South Africa, Saudi Arabia, UAE, and Israel. |
|
Key Market Segments Covered |
Product Type, Phase, Application, Region |
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Market Segments Covered in Clinical Trial Biorepository & Archiving Solutions Market Analysis
By Product Type:
- Preclinical Products
- Clinical Products
By Phase:
- Phase I
- Phase II
- Phase III
- Phase IV
By Application:
- Biorepository Services
- Archiving Solution Services
By Region:
- North America
- Latin America
- Europe
- APAC
- MEA
Frequently Asked Questions
How much is the current worth of the Clinical Trial Biorepository & Archiving Solutions Market?
The global Clinical Trial Biorepository & Archiving Solutions Market is worth more than US$ 3.5 Bn at present.
What is the sales forecast for Clinical Trial Biorepository & Archiving Solutions Market?
The value of the Clinical Trial Biorepository & Archiving Solutions Market is projected to increase at a CAGR of around 12.1% from 2022 – to 2032.
What was the last 5 year’s market CAGR?
The value of the Clinical Trial Biorepository & Archiving Solutions Market increased at a CAGR of around 9.9% from 2017 – to 2021.
What is a key trend shaping the growth of the market for the Clinical Trial Biorepository & Archiving Solutions Market?
The key trend driving the market growth are increased R&D investment and the availability of low-cost computers.
At what percentage is sales of Clinical Trial Biorepository & Archiving Solutions Market going to register growth in China?
The market for Clinical Trial Biorepository & Archiving Solutions Market in China is projected to expand at a CAGR of around 15.8% from 2022 – to 2032.
What do statistics for South Korea and Japan reveal?
While the market in South Korea is expected to grow at nearly 15.5%, the market in Japan is projected to register a CAGR of nearly 14.8% from 2022 – to 2032.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 4. Global Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 5.3.1. Preclinical Products 5.3.2. Clinical Products 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 6. Global Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032 6.3.1. Biorepository Services 6.3.1.1. Warehousing & Storage 6.3.1.2. Transportation 6.3.1.3. Sample Processing 6.3.1.4. Other Biorepository Services 6.3.2. Archiving Solution Services 6.3.2.1. Database Indexing and Management 6.3.2.2. Scanning & Destruction 6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021 6.5. Absolute $ Opportunity Analysis By Application, 2022-2032 7. Global Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Phase 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By Phase, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Phase, 2022-2032 7.3.1. Phase I 7.3.2. Phase II 7.3.3. Phase III 7.3.4. Phase IV 7.4. Y-o-Y Growth Trend Analysis By Phase, 2017-2021 7.5. Absolute $ Opportunity Analysis By Phase, 2022-2032 8. Global Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Application 9.2.4. By Phase 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Application 9.3.4. By Phase 9.4. Key Takeaways 10. Latin America Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Application 10.2.4. By Phase 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Application 10.3.4. By Phase 10.4. Key Takeaways 11. Europe Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. U.K. 11.2.1.5. Spain 11.2.1.6. Russia 11.2.1.7. BENELUX 11.2.1.8. Rest of Europe 11.2.2. By Product Type 11.2.3. By Application 11.2.4. By Phase 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Application 11.3.4. By Phase 11.4. Key Takeaways 12. Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. India 12.2.1.5. Rest of Asia Pacific 12.2.2. By Product Type 12.2.3. By Application 12.2.4. By Phase 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Application 12.3.4. By Phase 12.4. Key Takeaways 13. MEA Clinical Trial Biorepository & Archiving Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. GCC 13.2.1.2. Rest of MEA 13.2.2. By Product Type 13.2.3. By Application 13.2.4. By Phase 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Application 13.3.4. By Phase 13.4. Key Takeaways 14. Key Countries Clinical Trial Biorepository & Archiving Solutions Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Product Type 14.1.2.2. By Application 14.1.2.3. By Phase 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Product Type 14.2.2.2. By Application 14.2.2.3. By Phase 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Product Type 14.3.2.2. By Application 14.3.2.3. By Phase 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Product Type 14.4.2.2. By Application 14.4.2.3. By Phase 14.5. Argentina 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Product Type 14.5.2.2. By Application 14.5.2.3. By Phase 14.6. Germany 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Product Type 14.6.2.2. By Application 14.6.2.3. By Phase 14.7. Italy 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Product Type 14.7.2.2. By Application 14.7.2.3. By Phase 14.8. France 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Product Type 14.8.2.2. By Application 14.8.2.3. By Phase 14.9. U.K. 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Product Type 14.9.2.2. By Application 14.9.2.3. By Phase 14.10. Spain 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Product Type 14.10.2.2. By Application 14.10.2.3. By Phase 14.11. Russia 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Product Type 14.11.2.2. By Application 14.11.2.3. By Phase 14.12. BENELUX 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Product Type 14.12.2.2. By Application 14.12.2.3. By Phase 14.13. China 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Product Type 14.13.2.2. By Application 14.13.2.3. By Phase 14.14. Japan 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Product Type 14.14.2.2. By Application 14.14.2.3. By Phase 14.15. South Korea 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Product Type 14.15.2.2. By Application 14.15.2.3. By Phase 14.16. India 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Product Type 14.16.2.2. By Application 14.16.2.3. By Phase 14.17. GCC Countries 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Product Type 14.17.2.2. By Application 14.17.2.3. By Phase 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product Type 15.3.3. By Application 15.3.4. By Phase 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Brooks Life Science 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segment 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.2. Patheon 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segment 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.3. Precision for Medicine, Inc. 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segment 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.4. Medpace 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segment 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.5. LabCorp Drug Development 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segment 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.6. ATCC 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segment 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.7. Q2 Solutions 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segment 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.8. Labconnect 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segment 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.9. Charles River Laboratories 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segment 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.10. Cell&Co BioServices 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segment 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Region, 2017-2032 Table 2: Global Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 3: Global Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Application, 2017-2032 Table 4: Global Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Phase, 2017-2032 Table 5: North America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 6: North America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 7: North America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Application, 2017-2032 Table 8: North America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Phase, 2017-2032 Table 9: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 10: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 11: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Application, 2017-2032 Table 12: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Phase, 2017-2032 Table 13: Europe Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 14: Europe Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 15: Europe Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Application, 2017-2032 Table 16: Europe Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Phase, 2017-2032 Table 17: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 18: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 19: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Application, 2017-2032 Table 20: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Phase, 2017-2032 Table 21: MEA Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 22: MEA Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Product Type, 2017-2032 Table 23: MEA Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Application, 2017-2032 Table 24: MEA Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Forecast by Phase, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Product Type, 2022-2032 Figure 2: Global Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Application, 2022-2032 Figure 3: Global Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Phase, 2022-2032 Figure 4: Global Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Region, 2022-2032 Figure 5: Global Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Region, 2017-2032 Figure 6: Global Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Region, 2022-2032 Figure 7: Global Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Region, 2022-2032 Figure 8: Global Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 9: Global Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 10: Global Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 11: Global Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Application, 2017-2032 Figure 12: Global Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Application, 2022-2032 Figure 13: Global Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Application, 2022-2032 Figure 14: Global Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Phase, 2017-2032 Figure 15: Global Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Phase, 2022-2032 Figure 16: Global Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Phase, 2022-2032 Figure 17: Global Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Product Type, 2022-2032 Figure 18: Global Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Application, 2022-2032 Figure 19: Global Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Phase, 2022-2032 Figure 20: Global Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Region, 2022-2032 Figure 21: North America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Product Type, 2022-2032 Figure 22: North America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Application, 2022-2032 Figure 23: North America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Phase, 2022-2032 Figure 24: North America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Country, 2022-2032 Figure 25: North America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 26: North America Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 27: North America Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 28: North America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 29: North America Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 30: North America Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 31: North America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Application, 2017-2032 Figure 32: North America Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Application, 2022-2032 Figure 33: North America Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Application, 2022-2032 Figure 34: North America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Phase, 2017-2032 Figure 35: North America Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Phase, 2022-2032 Figure 36: North America Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Phase, 2022-2032 Figure 37: North America Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Product Type, 2022-2032 Figure 38: North America Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Application, 2022-2032 Figure 39: North America Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Phase, 2022-2032 Figure 40: North America Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Country, 2022-2032 Figure 41: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Product Type, 2022-2032 Figure 42: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Application, 2022-2032 Figure 43: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Phase, 2022-2032 Figure 44: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Country, 2022-2032 Figure 45: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 46: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 47: Latin America Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 48: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 49: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 50: Latin America Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 51: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Application, 2017-2032 Figure 52: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Application, 2022-2032 Figure 53: Latin America Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Application, 2022-2032 Figure 54: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Phase, 2017-2032 Figure 55: Latin America Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Phase, 2022-2032 Figure 56: Latin America Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Phase, 2022-2032 Figure 57: Latin America Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Product Type, 2022-2032 Figure 58: Latin America Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Application, 2022-2032 Figure 59: Latin America Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Phase, 2022-2032 Figure 60: Latin America Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Country, 2022-2032 Figure 61: Europe Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Product Type, 2022-2032 Figure 62: Europe Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Application, 2022-2032 Figure 63: Europe Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Phase, 2022-2032 Figure 64: Europe Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Country, 2022-2032 Figure 65: Europe Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 66: Europe Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 67: Europe Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 68: Europe Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 69: Europe Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 70: Europe Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 71: Europe Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Application, 2017-2032 Figure 72: Europe Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Application, 2022-2032 Figure 73: Europe Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Application, 2022-2032 Figure 74: Europe Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Phase, 2017-2032 Figure 75: Europe Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Phase, 2022-2032 Figure 76: Europe Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Phase, 2022-2032 Figure 77: Europe Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Product Type, 2022-2032 Figure 78: Europe Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Application, 2022-2032 Figure 79: Europe Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Phase, 2022-2032 Figure 80: Europe Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Country, 2022-2032 Figure 81: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Product Type, 2022-2032 Figure 82: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Application, 2022-2032 Figure 83: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Phase, 2022-2032 Figure 84: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Country, 2022-2032 Figure 85: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 86: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 87: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 88: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 89: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 90: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 91: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Application, 2017-2032 Figure 92: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Application, 2022-2032 Figure 93: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Application, 2022-2032 Figure 94: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Phase, 2017-2032 Figure 95: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Phase, 2022-2032 Figure 96: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Phase, 2022-2032 Figure 97: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Product Type, 2022-2032 Figure 98: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Application, 2022-2032 Figure 99: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Phase, 2022-2032 Figure 100: Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Country, 2022-2032 Figure 101: MEA Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Product Type, 2022-2032 Figure 102: MEA Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Application, 2022-2032 Figure 103: MEA Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Phase, 2022-2032 Figure 104: MEA Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) by Country, 2022-2032 Figure 105: MEA Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 106: MEA Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 107: MEA Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 108: MEA Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Product Type, 2017-2032 Figure 109: MEA Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Product Type, 2022-2032 Figure 110: MEA Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032 Figure 111: MEA Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Application, 2017-2032 Figure 112: MEA Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Application, 2022-2032 Figure 113: MEA Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Application, 2022-2032 Figure 114: MEA Clinical Trial Biorepository & Archiving Solutions Market Value (US$ Mn) Analysis by Phase, 2017-2032 Figure 115: MEA Clinical Trial Biorepository & Archiving Solutions Market Value Share (%) and BPS Analysis by Phase, 2022-2032 Figure 116: MEA Clinical Trial Biorepository & Archiving Solutions Market Y-o-Y Growth (%) Projections by Phase, 2022-2032 Figure 117: MEA Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Product Type, 2022-2032 Figure 118: MEA Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Application, 2022-2032 Figure 119: MEA Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Phase, 2022-2032 Figure 120: MEA Clinical Trial Biorepository & Archiving Solutions Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
